{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T17:55:41Z","timestamp":1725558941379},"publisher-location":"Berlin, Heidelberg","reference-count":65,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540705789"},{"type":"electronic","value":"9783540705796"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-70579-6_5","type":"book-chapter","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T07:46:30Z","timestamp":1277883990000},"page":"65-72","source":"Crossref","is-referenced-by-count":9,"title":["Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third"],"prefix":"10.1007","author":[{"given":"Kuno","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"5_CR1_5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/01.sla.0000118751.95179.c6","volume":"239","author":"MM Abdel-Latif","year":"2004","unstructured":"Abdel-Latif MM, O\u2019Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV (2004) NF-kappaB activation in esophageal adeno\u00adcarcinoma: relationship to Barrett\u2019s metaplasia, survival, and response to neoadjuvant chemo\u00ad\u00adradiotherapy. Ann Surg 239:491\u2013500","journal-title":"Ann Surg"},{"key":"5_CR2_5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/gut.2007.132662","volume":"57","author":"LA Anderson","year":"2008","unstructured":"Anderson LA, Murphy SJ, Johnston BT, Watson RGP, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV et al (2008) Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 57:734\u2013739","journal-title":"Gut"},{"key":"5_CR3_5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gut.47.6.753","volume":"47","author":"GS Arul","year":"2000","unstructured":"Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP (2000) Mucin gene expression in Barrett\u2019s oesophagus: an in situ hybridisation and immunohistochemical study. Gut 47:753\u2013761","journal-title":"Gut"},{"key":"5_CR4_5","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.2002.09.011","volume":"20","author":"MI Auvinen","year":"2002","unstructured":"Auvinen MI, Sihvo EI, Ruohtula T, Salminen JT, Koivistoinen A, Siivola P, Ronnholm R, Ramo JO, Bergman M, Salo JA (2002) Incipient angiogenesis in Barrett\u2019s epithelium and lymphangiogenesis in Barrett\u2019s adenocarcinoma. J Clin Oncol 20:2971\u20132979","journal-title":"J Clin Oncol"},{"key":"5_CR5_5","first-page":"135","volume":"152","author":"T Bailey","year":"1998","unstructured":"Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J (1998) Altered cadherin and catenin complexes in the Barrett\u2019s eso\u00adphagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and ded\u00adiffer\u00ad\u00ad\u00adentiation. Am J Pathol 152:135\u2013144","journal-title":"Am J Pathol"},{"key":"5_CR6_5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00042737-200502000-00014","volume":"17","author":"JY Barclay","year":"2005","unstructured":"Barclay JY, Morris A, Nwokolo CU (2005) Telomerase, hTERT and splice variants in Barrett\u2019s oesophagus and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol 17:221\u2013227","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5_CR7_5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/gast.2002.32370","volume":"122","author":"YS Bian","year":"2002","unstructured":"Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J (2002) p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett\u2019s esophagus. Gastroenterology 122:1113\u20131121","journal-title":"Gastroenterology"},{"key":"5_CR8_5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ije\/29.4.645","volume":"29","author":"AA Botterweck","year":"2000","unstructured":"Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645\u2013654","journal-title":"Int J Epidemiol"},{"key":"5_CR9_5","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1136\/gut.52.12.1678","volume":"52","author":"CJ Buskens","year":"2003","unstructured":"Buskens CJ, Sivula A, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimaki A (2003) Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus. Gut 52:1678\u20131683","journal-title":"Gut"},{"key":"5_CR10_5","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1053\/gast.2002.33580","volume":"122","author":"CJ Buskens","year":"2002","unstructured":"Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, Van Lanschot JJ, Ristimaki A (2002) Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 122:1800\u20131807","journal-title":"Gastroenterology"},{"key":"5_CR11_5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000111118","volume":"72","author":"D Cabuk","year":"2007","unstructured":"Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M, Turhal NS (2007) Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 72:111\u2013117","journal-title":"Oncology"},{"key":"5_CR12_5","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3748\/wjg.v10.i21.3194","volume":"10","author":"Y Chang","year":"2004","unstructured":"Chang Y, Gong J, Liu B, Zhang J, Dai F (2004) Gene expression profiling in Barrett\u2019s esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray. World J Gastroenterol 10:3194\u20133196","journal-title":"World J Gastroenterol"},{"key":"5_CR13_5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gut.49.6.761","volume":"49","author":"A Couvelard","year":"2001","unstructured":"Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Flejou JF (2001) Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 49:761\u2013766","journal-title":"Gut"},{"key":"5_CR14_5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH709>3.0.CO;2-F","volume":"192","author":"A Couvelard","year":"2000","unstructured":"Couvelard A, Paraf F, Gratio V, Scoazec JY, Henin D, Degott C, Flejou JF (2000) Angiogenesis in the neoplastic sequence of Barrett\u2019s oesophagus. Correlation with VEGF expression. J Pathol 192:14\u201318","journal-title":"J Pathol"},{"key":"5_CR15_5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1572-0241.2002.05529.x","volume":"97","author":"A Csendes","year":"2002","unstructured":"Csendes A, Smok G, Quiroz J, Burdiles P, Rojas J, Castro C, Henriquez A (2002) Clinical, endoscopic, and functional studies in 408 patients with Barrett\u2019s esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 97:554\u2013560","journal-title":"Am J Gastroenterol"},{"key":"5_CR16_5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"SS Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049\u20132053","journal-title":"Cancer"},{"key":"5_CR17_5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/gut.51.3.351","volume":"51","author":"MF Dixon","year":"2002","unstructured":"Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon ATR (2002) Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 51:351\u2013355","journal-title":"Gut"},{"key":"5_CR18_5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/modpathol.3800011","volume":"17","author":"A Driessen","year":"2004","unstructured":"Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, Penninckx F, Geboes K, Ectors N (2004) Identical cytokeratin expression pattern CK7+\/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 17:49\u201355","journal-title":"Mod Pathol"},{"key":"5_CR19_5","first-page":"5021","volume":"60","author":"CA Eads","year":"2000","unstructured":"Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV et al (2000) Fields of aberrant CpG island hypermethylation in Barrett\u2019s esophagus and associated adenocarcinoma. Cancer Res 60:5021\u20135026","journal-title":"Cancer Res"},{"key":"5_CR20_5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/gast.2001.27215","volume":"121","author":"W El-Rifai","year":"2001","unstructured":"El-Rifai W, Frierson HF Jr, Moskaluk CA, Harper JC, Petroni GR, Bissonette EA, Jones DR, Knuutila S, Powell SM (2001) Genetic differences between adenocarcinomas arising in Barrett\u2019s esophagus and gastric mucosa. Gas\u00adtroenterology 121:592\u2013598","journal-title":"Gastroenterology"},{"key":"5_CR21_5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gut.2005.089144","volume":"55","author":"RC Fitzgerald","year":"2006","unstructured":"Fitzgerald RC (2006) Molecular basis of Barrett\u2019s oesophagus and oesophageal adenocarcinoma. Gut 55:1810\u20131820","journal-title":"Gut"},{"key":"5_CR22_5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/mp.52.5.263","volume":"52","author":"JF Flejou","year":"1999","unstructured":"Flejou JF, Gratio V, Muzeau F, Hamelin R (1999) p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol Pathol 52:263\u2013268","journal-title":"Mol Pathol"},{"key":"5_CR23_5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2559.2003.01680.x","volume":"43","author":"U Flucke","year":"2003","unstructured":"Flucke U, Steinborn E, Dries V, Monig SP, Schneider PM, Thiele J, Holscher AH, Dienes HP, Baldus SE (2003) Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology 43:127\u2013134","journal-title":"Histopathology"},{"key":"5_CR24_5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/00000478-200310000-00008","volume":"27","author":"JN Glickman","year":"2003","unstructured":"Glickman JN, Shahsafaei A, Odze RD (2003) Mucin core peptide expression can help differentiate Barrett\u2019s esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol 27:1357\u20131365","journal-title":"Am J Surg Pathol"},{"key":"5_CR25_5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.dld.2005.01.008","volume":"37","author":"C Gulmann","year":"2005","unstructured":"Gulmann C, Lantuejoul S, Grace A, Leader M, Patchett S, Kay E (2005) Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT. Dig Liver Dis 37:439\u2013445","journal-title":"Dig Liver Dis"},{"key":"5_CR26_5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"5_CR27_5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00000658-200002000-00005","volume":"231","author":"AP Ireland","year":"2000","unstructured":"Ireland AP, Shibata DK, Chandrasoma P, Lord RV, Peters JH, DeMeester TR (2000) Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg 231:179\u2013187","journal-title":"Ann Surg"},{"key":"5_CR28_5","doi-asserted-by":"crossref","first-page":"10181","DOI":"10.1158\/0008-5472.CAN-07-2366","volume":"67","author":"C Iwata","year":"2007","unstructured":"Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M et al (2007) Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67:10181\u201310189","journal-title":"Cancer Res"},{"key":"5_CR29_5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/01.pai.0000209863.35828.dd","volume":"15","author":"F Kacar","year":"2007","unstructured":"Kacar F, Meteoglu I, Yasa H, Levi E (2007) Helicobacter pylori-induced changes in the gastric mucosa are associated with mitogen-\u00adactivated protein kinase (MAPK) activation. Appl Immuno\u00adhistochem Mol Morphol 15:224\u2013228","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"5_CR30_5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jnci\/djj393","volume":"98","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR (2006) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Heli\u00adcobacter pylori seropositivity. J Natl Cancer Inst 98:1445\u20131452","journal-title":"J Natl Cancer Inst"},{"key":"5_CR31_5","doi-asserted-by":"crossref","first-page":"G1000","DOI":"10.1152\/ajpgi.2000.278.6.G1000","volume":"278","author":"BS Kaur","year":"2000","unstructured":"Kaur BS, Ouatu-Lascar R, Omary MB, Triada\u00adfilopoulos G (2000) Bile salts induce or blunt cell proliferation in Barrett\u2019s esophagus in an acid-dependent fashion. Am J Physiol Gast\u00adrointest Liver Physiol 278:G1000\u2013G1009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5_CR32_5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/cncr.20966","volume":"103","author":"MA Kim","year":"2005","unstructured":"Kim MA, Lee HS, Yang HK, Kim WH (2005) Clinicopathologic and protein expression dif\u00adferences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer 103:1439\u20131446","journal-title":"Cancer"},{"key":"5_CR33_5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0016-5085(98)70016-2","volume":"115","author":"B Klump","year":"1998","unstructured":"Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R (1998) Hypermethylation of the CDKN2\/p16 promoter during neoplastic progression in Barrett\u2019s esophagus. Gastroenterology 115:1381\u20131386","journal-title":"Gastroenterology"},{"key":"5_CR34_5","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1245\/s10434-007-9484-7","volume":"14","author":"Y Kolev","year":"2007","unstructured":"Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K (2007) Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol 14:2738\u20132747","journal-title":"Ann Surg Oncol"},{"key":"5_CR35_5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323\u2013331","journal-title":"Cell"},{"key":"5_CR36_5","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.3748\/wjg.v11.i40.6360","volume":"11","author":"GS Liu","year":"2005","unstructured":"Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L (2005) Distinction between short-\u00adsegment Barrett\u2019s esophageal and cardiac intestinal metaplasia. World J Gastroenterol 11:6360\u20136365","journal-title":"World J Gastroenterol"},{"key":"5_CR37_5","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1158\/1078-0432.CCR-04-0839","volume":"10","author":"WA Marsman","year":"2004","unstructured":"Marsman WA, Birjmohun RS, van Rees BP, Caspers E, Johan G, Offerhaus A, Bosma PJ, Jan J, van Lanschot B (2004) Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia. Clin Cancer Res 10:8479\u20138485","journal-title":"Clin Cancer Res"},{"key":"5_CR38_5","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.athoracsur.2007.01.016","volume":"83","author":"S Mattioli","year":"2007","unstructured":"Mattioli S, Ruffato A, Di Simone MP, Corti B, D\u2019Errico A, Lugaresi ML, Mattioli B, D\u2019Ovidio F (2007) Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors. Ann Thorac Surg 83:1814\u20131819","journal-title":"Ann Thorac Surg"},{"key":"5_CR39_5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-4608(96)00087-8","volume":"90","author":"MB Menke-Pluymers","year":"1996","unstructured":"Menke-Pluymers MB, van Drunen E, Vissers KJ, Mulder AH, Tilanus HW, Hagemeijer A (1996) Cytogenetic analysis of Barrett\u2019s mucosa and adenocarcinoma of the distal esophagus and \u00adcardia. Cancer Genet Cytogenet 90:109\u2013117","journal-title":"Cancer Genet Cytogenet"},{"key":"5_CR40_5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M","volume":"83","author":"CP Morales","year":"1998","unstructured":"Morales CP, Lee EL, Shay JW (1998) In situ hybridization for the detection of telomerase RNA in the progression from Barrett\u2019s esophagus to esophageal adenocarcinoma. Cancer 83:652\u2013659","journal-title":"Cancer"},{"key":"5_CR41_5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(02)11569-8","volume":"360","author":"CP Morales","year":"2002","unstructured":"Morales CP, Souza RF, Spechler SJ (2002) Hallmarks of cancer progression in Barrett\u2019s oesophagus. Lancet 360:1587\u20131589","journal-title":"Lancet"},{"key":"5_CR42_5","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/1097-0142(20001101)89:9<1874::AID-CNCR2>3.3.CO;2-D","volume":"89","author":"JD Mueller","year":"2000","unstructured":"Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, Rudiger Siewert J (2000) Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 89:1874\u20131882","journal-title":"Cancer"},{"key":"5_CR43_5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s000180050449","volume":"56","author":"A Novak","year":"1999","unstructured":"Novak A, Dedhar S (1999) Signaling through beta-catenin and Lef\/Tcf. Cell Mol Life Sci 56:523\u2013537","journal-title":"Cell Mol Life Sci"},{"key":"5_CR44_5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10620-006-9399-3","volume":"52","author":"Z Nurgalieva","year":"2007","unstructured":"Nurgalieva Z, Lowrey A, El-Serag HB (2007) The use of cytokeratin stain to distinguish Barrett\u2019s esophagus from contiguous tissues: a systematic review. Dig Dis Sci 52:1345\u20131354","journal-title":"Dig Dis Sci"},{"key":"5_CR45_5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0046-8177(99)90007-2","volume":"30","author":"AH Ormsby","year":"1999","unstructured":"Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett\u2019s esophagus from intestinal metaplasia of the stomach. Hum Pathol 30:288\u2013294","journal-title":"Hum Pathol"},{"key":"5_CR46_5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5223(96)70441-5","volume":"111","author":"PM Schneider","year":"1996","unstructured":"Schneider PM, Casson AG, Levin B, Garewal HS, Hoelscher AH, Becker K, Dittler HJ, Cleary KR, Troster M, Siewert JR et al (1996) Mutations of p53 in Barrett\u2019s esophagus and Barrett\u2019s cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 111:323\u2013331; discussion 331\u2013323","journal-title":"J Thorac Cardiovasc Surg"},{"key":"5_CR47_5","first-page":"3153","volume":"6","author":"PM Schneider","year":"2000","unstructured":"Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR (2000) P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett\u2019s esophagus. Clin Cancer Res 6:3153\u20133158","journal-title":"Clin Cancer Res"},{"key":"5_CR48_5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jso.20582","volume":"94","author":"PG Schurr","year":"2006","unstructured":"Schurr PG, Yekebas EF, Kaifi JT, Lasch S, Strate T, Kutup A, Cataldegirmen G, Bubenheim M, Pantel K, Izbicki JR (2006) Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction. J Surg Oncol 94:307\u2013315","journal-title":"J Surg Oncol"},{"key":"5_CR49_5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.10215","volume":"94","author":"B Shen","year":"2002","unstructured":"Shen B, Ormsby AH, Shen C, Dumot JA, Shao YW, Bevins CL, Gramlich TL (2002) Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction. Cancer 94:820\u2013831","journal-title":"Cancer"},{"key":"5_CR50_5","first-page":"4879","volume":"61","author":"I Shureiqi","year":"2001","unstructured":"Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM (2001) Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61:4879\u20134884","journal-title":"Cancer Res"},{"key":"5_CR51_5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jso.20218","volume":"90","author":"JR Siewert","year":"2005","unstructured":"Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139\u2013146; discussion 146","journal-title":"J Surg Oncol"},{"key":"5_CR52_5","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457\u20131459","journal-title":"Br J Surg"},{"key":"5_CR53_5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-7404(00)00021-9","volume":"9","author":"HJ Stein","year":"2000","unstructured":"Stein HJ, Feith M, Siewert JR (2000) Cancer of the esophagogastric junction. Surg Oncol 9:35\u201341","journal-title":"Surg Oncol"},{"key":"5_CR54_5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bjc.6603583","volume":"96","author":"Y Tajima","year":"2007","unstructured":"Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, Aoki S, Kato M, Morohara K, Kusano M (2007) Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 96:631\u2013638","journal-title":"Br J Cancer"},{"key":"5_CR55_5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/00000478-200209000-00012","volume":"26","author":"P Taniere","year":"2002","unstructured":"Taniere P, Borghi-Scoazec G, Saurin JC, Lombard-Bohas C, Boulez J, Berger F, Hainaut P, Scoazec JY (2002) Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol 26:1213\u20131221","journal-title":"Am J Surg Pathol"},{"key":"5_CR56_5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/gut.52.2.174","volume":"52","author":"C Tselepis","year":"2003","unstructured":"Tselepis C, Morris CD, Wakelin D, Hardy R, Perry I, Luong QT, Harper E, Harrison R, Attwood SE, Jankowski JA (2003) Upregulation of the oncogene c-myc in Barrett\u2019s adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52:174\u2013180","journal-title":"Gut"},{"key":"5_CR57_5","first-page":"748","volume":"59","author":"H Dekken van","year":"1999","unstructured":"van Dekken H, Geelen E, Dinjens WN, Wijnhoven BP, Tilanus HW, Tanke HJ, Rosenberg C (1999) Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett\u2019s) and gastric cardia adenocarcinomas. Cancer Res 59:748\u2013752","journal-title":"Cancer Res"},{"key":"5_CR58_5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jcp.2004.024265","volume":"58","author":"MG Lier van","year":"2005","unstructured":"van Lier MG, Bomhof FJ, Leendertse I, Flens M, Balk AT, Loffeld RJ (2005) Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. J Clin Pathol 58:722\u2013724","journal-title":"J Clin Pathol"},{"key":"5_CR59_5","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.3748\/wjg.v12.i41.6608","volume":"12","author":"BH Rahden von","year":"2006","unstructured":"von Rahden BH, Stein HJ, Siewert JR (2006) Surgical management of esophagogastric junction tumors. World J Gastroenterol 12:6608\u20136613","journal-title":"World J Gastroenterol"},{"key":"5_CR60_5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/path.1260","volume":"199","author":"MM Weiss","year":"2003","unstructured":"Weiss MM, Kuipers EJ, Hermsen MA, van Grieken NC, Offerhaus J, Baak JP, Meuwissen SG, Meijer GA (2003) Barrett\u2019s adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. J Pathol 199:157\u2013165","journal-title":"J Pathol"},{"key":"5_CR61_5","first-page":"2929","volume":"58","author":"KT Wilson","year":"1998","unstructured":"Wilson KT, Fu S, Ramanujam KS, Meltzer SJ (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett\u2019s esophagus and associated adenocarcinomas. Cancer Res 58:2929\u20132934","journal-title":"Cancer Res"},{"key":"5_CR62_5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/carcin\/24.2.243","volume":"24","author":"J Wu","year":"2003","unstructured":"Wu J, Xia HHX, Tu SP, Fan DM, Lin MCM, Kung HF, Lam SK, Wong BCY (2003) 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 24:243\u2013247","journal-title":"Carcinogenesis"},{"key":"5_CR63_5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s004280000322","volume":"437","author":"M Yanagi","year":"2000","unstructured":"Yanagi M, Keller G, Mueller J, Walch A, Werner M, Stein HJ, Siewert JR, Hofler H (2000) Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach. Vir\u00adchows Arch 437:605\u2013610","journal-title":"Virchows Arch"},{"key":"5_CR64_5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/djh057","volume":"96","author":"W Ye","year":"2004","unstructured":"Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O (2004) Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96:388\u2013396","journal-title":"J Natl Cancer Inst"},{"key":"5_CR65_5","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1158\/0008-5472.CAN-07-5460","volume":"68","author":"C-J Yen","year":"2008","unstructured":"Yen C-J, Izzo JG, Lee D-F, Guha S, Wei Y, Wu T-T, Chen C-T, Kuo H-P, Hsu J-M, Sun H-L et al (2008). bile acid exposure up-regulates tuberous sclerosis complex 1\/mammalian target of rapamycin pathway in Barrett\u2019s-associated esophageal adenocarcinoma. Cancer Res 68:2632\u20132640","journal-title":"Cancer Res"}],"container-title":["Recent Results in Cancer Research","Adenocarcinoma of the Esophagogastric Junction"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-70579-6_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T11:02:48Z","timestamp":1552820568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-70579-6_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540705789","9783540705796"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-70579-6_5","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[2009]]}}}